Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone antibiotic presented as a sterile powder for reconstitution and injection for intravenous use. It treats a range of serious bacterial infections in adult patients, including community‑acquired pneumonia, complicated urinary tract infections, complicated intra‑abdominal infections, skin and soft tissue infections, and hospital‑acquired pneumonia.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levalox (levofloxacin) is a fluoroquinolone antibacterial used to treat infections caused by susceptible bacteria.

- Community‑acquired pneumonia: effective therapy to eradicate the causative bacterial pathogens and improve clinical outcomes. - Complicated urinary tract infections: eradicates Gram‑negative and Gram‑positive organisms, aiding resolution of infection. - Complicated intra‑abdominal infections: provides broad‑spectrum coverage for polymicrobial abdominal sepsis. - Skin and soft tissue infections: treats serious bacterial cellulitis and related conditions. - Hospital‑acquired pneumonia: targets resistant pathogens commonly encountered in nosocomial settings.

Levalox may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis after antibiotic exposure. - Severe allergic reactions: anaphylaxis, angioedema. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: life‑threatening skin reactions. - Peripheral neuropathy: persistent nerve pain or weakness.

Levalox requires careful consideration of patient‑specific factors before use. - Renal function: dose adjustment may be needed in patients with impaired clearance. - History of tendon disorders: avoid or monitor for tendon pain or inflammation. - QT prolongation risk: contraindicated in patients with known prolonged QT interval. - Concomitant use of NSAIDs: monitor for increased central nervous system stimulation. - Pregnancy and lactation: use only if clearly needed; safety not established. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Levalox can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Warfarin: may increase INR, requiring close coagulation monitoring. - Theophylline: increased plasma levels, risk of toxicity. - Other fluoroquinolones (e.g., ciprofloxacin): additive risk of tendon rupture. - Cyclosporine: elevated levofloxacin concentrations, monitor renal function.

Moderate Interactions (Monitor Closely): - NSAIDs: may heighten central nervous system stimulation. - Diabetes medications (insulin, sulfonylureas): potential for hypoglycemia. - Corticosteroids: increased risk of tendon injury. - Rifampin: may lower levofloxacin levels, reducing efficacy. - Oral contraceptives: possible reduced effectiveness, advise backup contraception.